305 related articles for article (PubMed ID: 28476783)
1. Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer.
Hagemann J; Jacobi C; Hahn M; Schmid V; Welz C; Schwenk-Zieger S; Stauber R; Baumeister P; Becker S
Anticancer Res; 2017 May; 37(5):2201-2210. PubMed ID: 28476783
[TBL] [Abstract][Full Text] [Related]
2. Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma.
Hagemann J; Jacobi C; Gstoettner S; Welz C; Schwenk-Zieger S; Stauber R; Strieth S; Kuenzel J; Baumeister P; Becker S
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29733308
[TBL] [Abstract][Full Text] [Related]
3. High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.
Kochanek SJ; Close DA; Johnston PA
Assay Drug Dev Technol; 2019 Jan; 17(1):17-36. PubMed ID: 30592624
[TBL] [Abstract][Full Text] [Related]
4. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
[TBL] [Abstract][Full Text] [Related]
5. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
6. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
7. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.
Al-Samadi A; Poor B; Tuomainen K; Liu V; Hyytiäinen A; Suleymanova I; Mesimaki K; Wilkman T; Mäkitie A; Saavalainen P; Salo T
Exp Cell Res; 2019 Oct; 383(2):111508. PubMed ID: 31356815
[TBL] [Abstract][Full Text] [Related]
8. Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation.
Singh M; Close DA; Mukundan S; Johnston PA; Sant S
Assay Drug Dev Technol; 2015 Nov; 13(9):570-83. PubMed ID: 26274587
[TBL] [Abstract][Full Text] [Related]
9. High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations.
Lee DW; Kim JE; Lee GH; Son A; Park HC; Oh D; Jo K; Choi C
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054773
[TBL] [Abstract][Full Text] [Related]
10. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
[TBL] [Abstract][Full Text] [Related]
11. Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
Raghavan S; Ward MR; Rowley KR; Wold RM; Takayama S; Buckanovich RJ; Mehta G
Gynecol Oncol; 2015 Jul; 138(1):181-9. PubMed ID: 25913133
[TBL] [Abstract][Full Text] [Related]
12. Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines.
Kochanek SJ; Close DA; Camarco DP; Johnston PA
SLAS Discov; 2020 Apr; 25(4):329-349. PubMed ID: 31983262
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity.
Raghavan S; Mehta P; Horst EN; Ward MR; Rowley KR; Mehta G
Oncotarget; 2016 Mar; 7(13):16948-61. PubMed ID: 26918944
[TBL] [Abstract][Full Text] [Related]
14. Early stage mechanical remodeling of collagen surrounding head and neck squamous cell carcinoma spheroids correlates strongly with their invasion capability.
Chen YQ; Kuo JC; Wei MT; Chen YC; Yang MH; Chiou A
Acta Biomater; 2019 Jan; 84():280-292. PubMed ID: 30500449
[TBL] [Abstract][Full Text] [Related]
15. Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.
Feng H; Ou BC; Zhao JK; Yin S; Lu AG; Oechsle E; Thasler WE
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1771-1786. PubMed ID: 28497169
[TBL] [Abstract][Full Text] [Related]
16. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
[TBL] [Abstract][Full Text] [Related]
17. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
18. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
[TBL] [Abstract][Full Text] [Related]
19. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
20. Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?
Friedrich J; Ebner R; Kunz-Schughart LA
Int J Radiat Biol; 2007; 83(11-12):849-71. PubMed ID: 18058370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]